Fig. 4 | Scientific Reports

Fig. 4

From: Implication of an exosome-based gene signature for estimating clinical outcomes of triple-negative breast cancer and assisting in individualized therapy

Fig. 4

Heterogeneous genetic mutations across low- and high-risk TNBC tumors. (A, B) Copy number amplifications and losses in high-risk tumors. The threshold was set as q-value of 0.25. (C, D) Copy number amplifications and losses in low-risk tumors. (E, F) Waterfall plots illustrating the first twenty mutated genes in high- or low-risk tumors. (G) Differential OS outcomes between low and high TMB tumors. (H) Differential OS outcomes among four groups stratified by the risk score and TMB.

Back to article page